Answers are grounded in this paper and cite their sources.
The prevalence of chronic kidney disease (CKD) is increasing because of multiple factors, including rising life expectancy. Kidney transplantation is a form of kidney replacement therapy, alongside haemodialysis and peritoneal dialysis, that prolongs and improves the quality of life of patients with end-stage renal disease (ESRD). Compared with patients receiving dialysis, kidney transplant recipients generally have better survival and quality of life. One of the major challenges in kidney transplantation is the considerable heterogeneity of recipient comorbidities, which directly affects patient selection and post-transplant outcomes. A better understanding of the spectrum and impact of comorbid conditions before transplantation may improve candidate evaluation, guide post-transplant monitoring, and help refine prognostic algorithms. Further research is required to develop individualized approaches to assessing the risks associated with age, comorbidities, and other relevant factors, thereby improving kidney transplant outcomes. The review summarizes the available scientific evidence on comorbidities among kidney transplant recipients .
No takes yet. Share an insight, caveat, or question.
Murkamilov et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: